Q2 2023 · 13F-HR
Vivo Capital, LLCholdings as filed
Filed 2023-08-14 · accession 0001213900-23-067000
$1.45B
Reported value
48
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| P8696W104 | SVA | Sinovac Biotech Ltd. | $615.4M | 42.5% | 5,900,000 | Common | SOLE |
| 413197104 | HRMY | Harmony Biosciences Holdings Inc | $91.7M | 6.33% | 2,606,247 | Common | SOLE |
| 925050106 | VRNA | Verona Pharma PLC | $89.8M | 6.20% | 4,249,918 | Common | SOLE |
| 05337M104 | — | Avadel Pharmaceuticals PLC | $63.1M | 4.36% | 3,829,577 | Common | SOLE |
| 880881107 | 430 | Terns Pharmaceuticals Inc | $58.3M | 4.02% | 6,657,992 | Common | SOLE |
| 374163103 | GERN | Geron Corp | $53.0M | 3.66% | 16,524,634 | Common | SOLE |
| 87650L103 | TARS | Tarsus Pharmaceuticals Inc | $40.9M | 2.82% | 2,262,200 | Common | SOLE |
| 92790C104 | VRDN | Viridian Therapeutics Inc | $39.9M | 2.76% | 1,678,207 | Common | SOLE |
| H9060V101 | — | VectivBio Holding AG | $39.4M | 2.72% | 2,333,300 | Common | SOLE |
| 16961L106 | — | Chinook Therapeutics Inc | $35.9M | 2.48% | 934,879 | Common | SOLE |
| 00166B105 | ALXO | ALX Oncology Holdings Inc | $31.7M | 2.19% | 4,220,048 | Common | SOLE |
| 19240Q201 | COGT | Cogent Biosciences Inc | $26.6M | 1.83% | 2,244,941 | Common | SOLE |
| 45114M109 | — | Icosavax, Inc. | $16.9M | 1.17% | 1,704,568 | Common | SOLE |
| 38406L103 | — | Gracell Biotechnologies Inc | $15.1M | 1.04% | 3,969,427 | Common | SOLE |
| 04635X102 | CATBUSD | Astria Therapeutics Inc | $14.0M | 0.97% | 1,681,199 | Common | SOLE |
| 92332V107 | VTYXUSD | Ventyx Biosciences Inc | $13.8M | 0.96% | 422,075 | Common | SOLE |
| 03940C100 | ACLXGBX | Arcellx Inc. | $13.7M | 0.95% | 433,785 | Common | SOLE |
| 01671P100 | ALLKGUSD | Allakos Inc | $13.0M | 0.90% | 2,988,000 | Common | SOLE |
| 98887Q104 | ZLAB | Zai Lab Ltd ADR | $12.4M | 0.85% | 445,505 | Common | SOLE |
| 68062P106 | OLMA | Olema Pharmaceuticals Inc | $12.1M | 0.83% | 1,339,271 | Common | SOLE |
| 92337C203 | VSTM | Verastem Inc | $11.4M | 0.79% | 1,538,461 | Common | SOLE |
| 20454B104 | CMPX | Compass Therapeutics Inc | $11.3M | 0.78% | 3,556,023 | Common | SOLE |
| 04522R101 | — | Aslan Pharmaceuticals Ltd | $10.4M | 0.72% | 2,840,908 | Common | SOLE |
| 02083G100 | NVLSEUR | Alpine Immune Sciences Inc | $9.4M | 0.65% | 914,913 | Common | SOLE |
| 00461U105 | ACRS | Aclaris Therapeutics, Inc. | $9.3M | 0.64% | 898,631 | Common | SOLE |
| 03236M200 | — | Amyris, Inc | $8.0M | 0.55% | 7,750,828 | Common | SOLE |
| 483497103 | KALV | KalVista Pharmaceuticals Inc. | $7.7M | 0.53% | 856,008 | Common | SOLE |
| 37186H100 | — | Genetron Holdings Ltd | $7.6M | 0.52% | 8,124,174 | Common | SOLE |
| 45783C101 | — | Instil Bio Inc | $6.9M | 0.47% | 12,486,787 | Common | SOLE |
| 24661P807 | DCTH | Delcath Systems, Inc. | $6.9M | 0.47% | 1,178,787 | Common | SOLE |
| 26818M108 | DYN | Dyne Therapeutics Inc | $6.5M | 0.45% | 577,642 | Common | SOLE |
| 00032Q104 | WHWK | Aadi Bioscience Inc | $6.5M | 0.45% | 509,572 | Common | SOLE |
| 81749D107 | SERA | Sera Prognostics Inc | $6.1M | 0.42% | 1,856,011 | Common | SOLE |
| 449778109 | IOBTQ | IO Biotech Inc | $5.9M | 0.41% | 3,015,545 | Common | SOLE |
| 23306J101 | — | DBV Technologies SA | $5.1M | 0.36% | 2,708,875 | Common | SOLE |
| 097702104 | BOLT1EUR | Bolt Therapeutics Inc | $5.0M | 0.34% | 3,871,291 | Common | SOLE |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals Inc | $4.9M | 0.34% | 137,411 | Common | SOLE |
| 462260100 | IOVA | Iovance Biotherapeutics Inc | $4.6M | 0.32% | 655,057 | Common | SOLE |
| 185634102 | CLNNEUR | Clene Inc | $3.7M | 0.26% | 4,520,622 | Common | SOLE |
| 45258K109 | — | Impel NeuroPharma Inc | $3.7M | 0.25% | 2,884,789 | Common | SOLE |
| 01626L105 | — | Aligos Therapeutics Inc | $3.4M | 0.24% | 3,547,030 | Common | SOLE |
| 09077B104 | BCABGBP | BioAtla Inc | $1.9M | 0.13% | 637,181 | Common | SOLE |
| 359616109 | FULC | Fulcrum Therapeutics Inc | $1.8M | 0.13% | 550,000 | Common | SOLE |
| 4525EP101 | VTLUSD | Immunic Inc | $1.6M | 0.11% | 632,184 | Common | SOLE |
| 192005106 | CDXS | Codexis, Inc | $1.1M | 0.08% | 388,144 | Common | SOLE |
| 76200L309 | RZLT | Rezolute Inc | $969,157 | 0.07% | 489,473 | Common | SOLE |
| 438083107 | FIXXEUR | Homology Medicines, Inc. | $327,510 | 0.02% | 370,068 | Common | SOLE |
| 74019P108 | — | Precision Biosciences Inc | $73,774 | 0.01% | 140,255 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.